Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Rating) saw a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 638,800 shares, an increase of 167.6% from the April 30th total of 238,700 shares. Based on an average daily volume of 217,100 shares, the days-to-cover ratio […]
Stock analysts at StockNews.com began coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Rating) in a research report issued on Thursday. The brokerage set a “sell” rating on the stock. Tonix Pharmaceuticals Stock Performance Shares of NASDAQ TNXP traded down $0.03 during mid-day trading on Thursday, reaching $1.86. The company’s stock had a trading […]
StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Rating) in a research note published on Saturday. The brokerage issued a sell rating on the stock. Separately, Alliance Global Partners restated a buy rating and set a $6.50 price objective on shares of Tonix Pharmaceuticals in a report on Thursday, January 12th. Tonix […]